Mount Sinai Ophthalmology Faculty Practice Associates
New York, 10029, United States
NCT Number: NCT04980430
Virtual reality (VR) is a relatively new, emerging field within healthcare. Studies have analyzed public perceptions of virtual reality in healthcare using social media, but few have actually demonstrated and educated these modalities to communities. Because vision care can be costly and inaccessible, especially in communities with few physicians, this study aims to evaluate whether communities would be open to new technology. For example, it has been determined that 80% of vision loss is preventable with adequate screening technology, a key factor in ameliorating the economic and emotional burden of eye disease. Therefore, through demonstrations and educational presentations by medical students, gaps in understanding perceptions, willingness to adopt, and general demographics of those seeking better eye care will be understood.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
New York, 10029, United States
This study is critical to show healthcare leaders that communities seek new, lower cost, and more accessible technologies for vision care. This study will also be used to expand use of the technology in other communities and prove a use case for it. Ultimately, this can help benefit communities to ensure that all are receiving proper vision care and to address common conditions in a timely manner.
If participants agree to participate, individuals will be educated about vision care and the use of virtual reality technology by a medical student or trained volunteer using a VR headset. This entire process will take about 5 minutes. Participants will be allowed to take breaks and medical students and/or volunteers will be nearby to answer any questions they may have throughout the study. There will be no results given to patients during the study nor will they be advised to use any information to inform future healthcare decisions. The purpose of the study is demonstrative.
After the demonstration, a survey will be given to each participant about their experience with the VR technology along with demographic information. This will be kept confidential and will only be accessed by those approved. The survey will take approximately 5 minutes. In addition, we will offer educational materials on the conditions that the vision tests are used to screen for.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Virtual Reality Demonstration
Time frame: Day 1
Participant assessment of VR technology. Items scored on a likert-scale format from 1 (strongly disagree) to 5 (strongly agree). Full scale from 13 to 65, with higher score indicating more favorable responses.
Time frame: Day 1
Survey to evaluate participant demographics and vision care needs. This is not a scored or scaled survey.
Icahn School of Medicine at Mount Sinai
Other
Evaluating Community Interest in Virtual Reality Vision Screening Technology
Acronym: RTS2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07581925
Artificial Intelligence (AI), Digestive System Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT05294640
Anesthesia, Local, Bacterial Infections
San Francisco, California, United States
View Trial DetailsNCT04327752
Allergic Skin Reaction, Biotherapy
Amiens, France
View Trial DetailsNCT04213183
Artificial Intelligence, Digestive System Diseases
Guangzhou, Guangdong, China
View Trial Details